long-arrow-pointing-to-left linkedin twitter facebook mail
BATTELLE

Detecting Neurobehavioral Effects

Battelle's white paper will help you understand how neurobehavioral toxicology testing provides the critical insights you need to make informed decisions to help you reach your end goal. But where do you begin—and who can you trust to deliver appropriately standardized tests?

question

what’s inside

Does a potential new blood pressure drug have negative effects on the nervous system? Which therapies show the most promise for treatment of Alzheimer’s disease? Are growing rates of neuropsychiatric disorders, such as Attention Deficit Hyperactivity Disorder (ADHD) and autism, linked to chemical exposure? How can we protect soldiers and civilians who are at risk from exposure to chemical weapons?

Neurobehavioral testing aims to answer these and other important questions. But all testing preclinical CROs are not created equal. How can you choose the right partner for your specific neuro-tox challenge?

Download Battelle's white paper - Detecting Neurobehavioral Effects: Considerations in the Design & Execution of Neurobehavioral Studies - to learn:

4 Primary Industries that Benefit from Neurobehavioral testing

6 critical considerations when selecting a preclinical CRO for testing

3 Tiers of Neurobehavioral Testing & What to know about each

Overview of neurobehavioral testing capabilities at Battelle

bg-form

apply what you learn

Neurobehavioral testing is a subset of neurotoxicology focused specifically on measurable effects on central nervous system (CNS) and peripheral nervous system (PNS) function, sensorimotor and locomotor activity, neuromuscular integrity, reflex responses, perception and cognition, including learning and memory.

Learn more in our white paper by providing just a bit of information on the right.

get the white paper

This field is required Would you like to receive updates from Battelle?

Please refer to our PRIVACY POLICY for more information.